|
Real-time Estimate
Tradegate
19:14:35 22/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.814 EUR | -0.35% |
|
+0.72% | -48.61% |
| 09-18 | Evotec at the top of the SDax - Positive comments at a conference | DP |
| 09-09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 46.68B | |||||
| 44.42B | |||||
| 41.32B | - | - | - | - | - |
| 41.58B | |||||
| 30.14B |
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
- Charts Evotec SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
